27.09.2014 Views

Program - Society of Toxicology

Program - Society of Toxicology

Program - Society of Toxicology

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

44 th Annual Meeting<br />

and ToxExpo<br />

<strong>Program</strong> Description<br />

#1166 ROLE OF EUKARYOTIC TRANSLATION<br />

INITIATION FACTOR 4E (EIF4E) IN CADMIUM-<br />

INDUCED CYTOTOXICITY AND CELL DEATH.<br />

S. Othumpangat and P. Joseph. <strong>Toxicology</strong> and<br />

Molecular Biology Branch, NIOSH, Morgantown, WV.<br />

#1167 MECHANISMS OF ARSENITE-STIMULATED<br />

HEMEOXYGENASE-1 UPREGULATION IN<br />

HUMAN KERATINOCYTES. K. L. Cooper and L. G.<br />

Hudson. College <strong>of</strong> Pharmacy, University <strong>of</strong> NM,<br />

Albuquerque, NM.<br />

#1168 MERCURY, CADMIUM, ZINC, AND ARSENITE<br />

INHIBIT PAX3 DNA BINDING VIA THE PAIRED<br />

DOMAIN. F. A. Leal 1 , A. F. Machado 2 , M. D. Collins 1<br />

and J. M. Fukuto 1 . 1 Molecular <strong>Toxicology</strong> IDP,<br />

University <strong>of</strong> California, Los Angeles, CA and<br />

2 Department <strong>of</strong> Environmental and Occupational<br />

Health, California State University, Northridge, CA.<br />

Sponsor: O. Hankinson.<br />

#1169 NFκB MEDIATES ZINC-INDUCED COX-2<br />

EXPRESSION IN HUMAN BRONCHIAL<br />

EPITHELIAL CELLS. W. wu 1 . 1 Center for<br />

Environmental Medicine, University <strong>of</strong> North Carolina,<br />

Chapel Hill, NC and 2 Human Studies Division, U.S.<br />

EPA, Research Triangle Park, NC. Sponsor: M.<br />

Madden.<br />

Tuesday Afternoon, March 8<br />

1:30 PM to 4:30 PM<br />

Exhibit Hall<br />

POSTER SESSION: PHARMACEUTICALS-METHODS OF<br />

EVALUATION<br />

Chairperson(s): Patrick Hayden, MatTek Corporation, Ashland, MA.<br />

Displayed: 1:30 PM–4:30 PM<br />

Attended: 3:00 PM–4:30 PM<br />

#1170 COMPARISON OF BCNU AND SARCNU<br />

TOXICITY IN LONG-TERM CULTURES OF<br />

PRECISION-CUT LUNG SLICES. C. A. Tyson, K.<br />

Amin, C. Ip and H. P. Behrsing. <strong>Toxicology</strong> Laboratory,<br />

SRI International, Menlo Park, CA.<br />

#1171 A HIGH-THROUGHPUT IN VITRO MODEL OF<br />

HUMAN TRACHEAL/BRONCHIAL<br />

EPITHELIUM (EPIAIRWAY) FOR PRECLINICAL<br />

SAFETY AND EFFICACY TESTING OF<br />

PHARMACEUTICALS. P. J. Hayden, G. R. Jackson,<br />

J. Kubilus, J. E. Sheasgreen and M. Klausner. MatTek<br />

Corp., Ashland, MA.<br />

#1172 VASCULAR PERMEABILITY IN THE RAT. S.<br />

Rowton and P. Robinson. Covance Laboratories Ltd.,<br />

Harrogate, United Kingdom. Sponsor: D. Everett.<br />

#1173 REDUCED STRESS IN GROUP HOUSED NON-<br />

HUMAN PRIMATES. S. Grainger 1 , J. Hedley 1 and M.<br />

Nieh<strong>of</strong> 2 . 1 Covance Laboratories Ltd., Harrogate, United<br />

Kingdom and 2 Covance Laboratories GmbH, Munster,<br />

Germany. Sponsor: D. Everett.<br />

#1174 PREDICTING ANTIEPILEPTIC DRUG<br />

TOXICITY USING HEPATIC PROTEIN<br />

COVALENT BINDING AND GENE EXPRESSION<br />

POTENTIAL. A. M. Leone 1 , L. M. Kao 1 , M.<br />

McMillian 1 , A. Y. Nie 1 , J. B. Parker 1 , M. F. Kelley 1 , M.<br />

D. Johnson 1 , E. Usuki 2 , A. Parkinson 2 and P. Lord 1 .<br />

1 Mechanistic <strong>Toxicology</strong>, Johnson & Johnson<br />

Pharmaceutical Research & Development, L.L.C.,<br />

Raritan, NJ and 2 XenoTech LLC, Lenexa, KS.<br />

#1175 IN VIVO AND IN VITRO NON-CLINICAL DRUG<br />

SAFETY ASSESSMENT: A KEY PARTNER FOR<br />

ANTICANCER DRUG DEVELOPMENT. N. Lhote 1 ,<br />

Y. Sibiril 3 , D. Bazot 1 , A. Beamonte 1 , J. Delongeas 1 , D.<br />

Parent-Massin 3 and N. Claude 2 . 1 Servier Group, Gidy,<br />

France, 2 Servier Group, Courbevoie, France and 3 LTA<br />

EA3880, UBO Brest, France.<br />

#1176 PHARMACOKINETICS AND ENHANCED ORAL<br />

BIOAVAILABILITY OF NANOSTRUCTURED<br />

DRUG CRYSTALS: COMPARISON OF<br />

PARTICLE ENGINEERING TECHNOLOGIES<br />

FOR DANAZOL, KETOCONAZOLE AND<br />

NAPROXEN IN BEAGLE DOGS. G. G.<br />

Kupperblatt 2 , S. A. Saghir 1 , D. A. Markham 1 , T. L.<br />

Rogers 2 , C. J. Tucker 3 , J. E. Hitt 2 and E. J. Elder 2 .<br />

1 <strong>Toxicology</strong> & Environmental Research & Consulting,<br />

The Dow Chemical Company, Midland, MI,<br />

2 Dowpharma, The Dow Chemical Company, Midland,<br />

MI and 3 Corporate R&D, The Dow Chemical Company,<br />

Midland, MI.<br />

#1177 REDUCTION AND REFINEMENT IN<br />

RADIOLABELLED PRIMATE METABOLISM<br />

STUDIES. J. Kelly, J. Hedley and R. Allen. Covance<br />

Laboratories Ltd., Harrogate, United Kingdom.<br />

Sponsor: D. Everett.<br />

#1178 ADJUVANT ARTHRITIS IN THE MALE LEWIS<br />

RAT. S. Rowton and P. Robinson. Covance<br />

Laboratories Ltd., Harrogate, United Kingdom.<br />

Sponsor: D. Everett.<br />

Tuesday Afternoon, March 8<br />

1:30 PM to 4:30 PM<br />

Exhibit Hall<br />

POSTER SESSION: SAFETY EVALUATION-NON<br />

PHARMACEUTICAL<br />

Chairperson(s): Eugenia Theophilus, R.J. Reynolds Tobacco Company,<br />

Winston Salem, NC.<br />

Displayed: 1:30 PM–4:30 PM<br />

Attended: 1:30 PM–3:00 PM<br />

#1179 EVALUATION OF GENOTOXICITY AND<br />

SENSITIZATION POTENTIAL OF PEPTIDE<br />

COUPLING REAGENTS. D. A. Seid 1 , S. S. Kim 2 and<br />

S. Kim 1 . 1 Applied Biosystems, Foster City, CA and<br />

2 University <strong>of</strong> California, Berkeley, CA.<br />

#1180 COMPARISON OF PHOTOTOXICITY TESTING<br />

METHODS USED TO SCREEN LEAD<br />

COMPOUNDS L. LEE, G. STEVENS, AND B.<br />

JESSEN. PFIZER GLOBAL R&D. L. Lee. Pfizer<br />

Global R&D, San Diego, CA. Sponsor: G. Stevens.<br />

TUESDAY<br />

up-to-date information at www.toxicology.org 139

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!